欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号AT/H/1398/001
药品名称Naproxen/Esomeprazol 500 mg/20 mg modified release tablets
活性成分
    • Esomeprazole magnesium trihydrate 20.0 mg
    • Naproxen 500.0 mg
剂型Modified-release tablet
上市许可持有人Teva B.V. Swensweg 5 Haarlem 2031 GA Netherlands
参考成员国 - 产品名称Austria (AT)
互认成员国 - 产品名称
    • Spain (ES)
    • Lithuania (LT)
      Nesoran 500 mg/20 mg modifikuoto atpalaidavimo tabletės
    • Latvia (LV)
    • Poland (PL)
      Naproxen/ Esomeprazole Teva
    • Portugal (PT)
    • Romania (RO)
      Naproxen/Esomeprazol Teva 500 mg/20 mg comprimate cu eliberare modificata
    • Bulgaria (BG)
    • Germany (DE)
      Naproxen/Esomeprazol-ratiopharm 500 mg/20 mg Tabletten mit veränderter Wirkstofffreisetzung
    • Estonia (EE)
许可日期2025/04/30
最近更新日期2025/07/18
药物ATC编码
    • M01AE52 naproxen and esomeprazole
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
    ©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase